Marianne Jansson
41 – 50 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model
(
- Contribution to journal › Article
-
Mark
Effect of Complement on HIV-2 Plasma Antiviral Activity Is Intratype Specific and Potent
(
- Contribution to journal › Article
-
Mark
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
(
- Contribution to journal › Article
-
Mark
R5 HIV-1 with efficient DC-SIGN use is not selected for early after birth in vertically infected children.
(
- Contribution to journal › Article
-
Mark
Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.
(
- Contribution to journal › Article
-
Mark
Frequent intratype neutralization by plasma immunoglobulin A identified in HIV-2 infection.
(
- Contribution to journal › Article
- 2012
-
Mark
Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1
(
- Contribution to journal › Article
-
Mark
Mycobacteria-infected bystander macrophages trigger maturation of dendritic cells and enhance their ability to mediate HIV transinfection
(
- Contribution to journal › Article
-
Mark
Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
(
- Contribution to journal › Article
-
Mark
Tuberculosis and HIV Co-Infection
(
- Contribution to journal › Scientific review